- How DSOs are growing in 11 battleground states
- CMS appeals Clover’s Medicare Advantage star ratings win
- Craneware cybersecurity incident could affect up to 147M patient records
- Orthopedics’ outpatient success is becoming a payment debate
- Missouri system foundation president exits; interim named
- Justice Department opens DEI probes into 5 more medical schools
- CEO-to-staff pay disparity widest at largest systems: Study
- Illinois hospital gets 6 more months to reopen
- PA licensure compact grows to 29 states
- CHS Q2 profit down 75% as hospital footprint falls to 60: 7 things to know
- Healthcare’s top lobbying spenders in 2026 so far
- Cleveland Clinic scales lab as cyclospora tests jump from 1-2 daily to 400
- Patients battle billing challenges at Florida PDS Health practices: 6 notes
- The new gold standard in ASC design
- Dr. Hani Najm appointed as ACC’s next president
- ‘We are our own worst enemy’: Why dentistry needs to stand up to payers
- What 5 of the largest DSOs have been up to
- 6 findings that complicate the private equity-healthcare narrative
- Community Health Systems misses on Q2 earnings, revenue
- Washington DC weighs interstate dental compact bill
- CMS appeals court decision behind 2026 MA star ratings recalculations
- 3 challenges the dental industry can’t shake
- CMS expands navigation coverage: What to know
- Boulder Care awarded NIH grant to provide SUD care in complex settings
- ASA, ABA add perioperative medicine to anesthesiology board exam
- EDs account for 73% of non-acute suicide incidents, ECRI data shows
- Cascadia Health faces $51M wrongful death lawsuit: 6 things to know
- CMS proposed rule lays groundwork for more OBBBA provider tax cutbacks
- The Meadows unveils digital patient companion
- The operational challenges DSO leaders can’t ignore
- Michigan ASC suffers data breach
- Measles Cases Set 35-Year US Record With Months To Go In 2026
- Taylor Farms Faces Cyclospora Outbreak, Recalls And Political Questions
- Why Elevate’s Co-Founder Answers the Phone Himself
- Cardinal Health taps new president of The Specialty Alliance
- DDSmatch Launches First-of-Its-Kind Mobile App to Revolutionize Dental Practice Transitions
- GSK secures first lung cancer approval as FDA clears Jideytro in quick payoff from Nuvalent deal
- Illinois replacement hospital to triple psychiatric beds, add adolescent unit
- ‘HHS should have acted years ago’: Court rules against AANA in CRNA reimbursement fight
- The biggest DSO acquisitions in 2026
- Yale New Haven Children’s Hospital launches pediatric crisis center
- Smith+Nephew goes beyond implants with end-to-end ASC strategy
- Visana revamps well-woman visit to comprehensively address symptoms
- The key to earning physician support for standardization and 3 more supply chain updates
- 7 behavioral health layoffs to know | 2026
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- What to Expect at PODD 2026
- Candid Health secures $120M series D as investment in AI-powered RCM ramps up
- GLP-1 Use Surges Among Young People With Obesity
- Erlanger Health System signs letter of intent to join Prisma Health
- FDA calls out Sanofi emails for giving 'misleading impression' of Beyfortus use in RSV
- Samsung launches beta version of AI-powered health assistant across US
- States with the most, fewest at-risk youth
- Look out Ionis, here comes Arrowhead with promising hypertriglyceridemia data
- Trump floats countdown to 200% tariffs on generic drugs imported to US
- Summit Therapeutics updates ivonescimab survival data ahead of FDA decision date
- How Does ADHD Affect Athletes' Concussion Risk?
- 1 In 4 Americans Stuck In Jobs For Health Insurance, Survey Finds
- TV Does Indeed Rot Your Brain, Study Says
- A more connected approach to prenatal care
- Tick-Borne Meat Allergy: Many Carry Alpha-Gal Antibodies Without Symptoms
- Agencies In New York And Beyond Pass The Buck On Opioid Cash Oversight
- Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records
- American Scientists See Prosecutions as Part of Federal Campaign Against Them
- Sanofi reprimanded for disparaging Pfizer’s RSV vaccine
- How is $58B in opioid settlement money being spent? 5 things to know
- From crisis response to care orchestration — 4 takeaways for behavioral health leaders
- Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
- Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
- Delaware passes laws on hospital price caps, PE purchases, financial assistance
- Startup Assured banks $19M to build out AI-powered platform for provider onboarding
- Cardinal Health to buy Strive Medical, AdaptHealth's diabetes health business for $360M
- OIG: States can improve enforcement of Medicaid MCOs' fraud referrals
- Amgen agrees to $74M settlement to resolve investor lawsuit over potential $10.7B tax bill
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- AdventHealth, Intermountain Health plan to form Denver-area joint venture
- Remarks to the Small Business Capital Formation Advisory Committee
- Cannabis Drinks Sold Next To Soda Are Sending Kids To The ER, Doctors Say
- Sanofi continues tweaks to executive roster as new CEO Garijo settles in
- Coffee May Lower Your Heart Disease Risk, But How Much Is Safe?
- T. Denny Sanford, billionaire philanthropist and Sanford Health namesake, dies at 90
- Alembic site slapped with FDA warning letter over patient consent concerns
- Trump admin pausing over $1B in Medicaid payments to California, Minnesota
- Lilly, BMS aerospace partner Redwire opens new site in Indiana
- Novartis CEO brushes off oral PCSK9 competition as Leqvio drives Q2 growth
- More Than Half Of US Adults Should Be Offered Statins, Study Says
- Gait Training Can Help Knee Arthritis
- The Best Surgery For Pelvic Organ Prolapse?
- Karoo Health lands $16.2M series A to advance value-based cardiology platform
- Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads
- Doctors 'Cringe' At Possibility Of Documenting Which Medicaid Enrollees Are Too Sick to Work
- Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages
- Severely Ill Prisoners Granted Early Release Are Left Stuck Behind Bars
- Leadership Vacuum: Agencies in New York and Beyond Pass the Buck on Opioid Cash Oversight
- A Deloitte-Run System Denied Medicaid Benefits for Michigan’s Disabled. Now Trump’s Law Piles On.
- Gilead, Merck’s phase 3 data back first weekly HIV pill
- J&J’s Tremfya remains on top in Q2 pharma ad spending league as overall outlay drops
- DHS decouples duration of some visas from training program length
- AI emerges as top healthcare IT investment globally, KLAS finds
- Healthcare affordability, fraud are key issues for voters heading into 2026 midterms
- FDA: Iceberg Lettuce Recall Stands After False Positive For Cyclospora
- Clover Health reveals data breach in SEC filing
- Why Do So Many Women Miss The Signs Of Perimenopause?
- J&J, Time link up to spotlight healthcare leadership with Healthcare Champion of the Year award
- Health systems need to prepare for an AI-driven reinvention of work, Abundant Alliance's Eric Langshur says
- Healthcare bankruptcy volume 'stabilizes' in H1, though more practices are falling under
- Sanofi survey uncovers Type 1 diabetes misconceptions and screening gaps
- Samsung Biologics spreads wings with proposed $1.8B acquisition of Swiss CDMO PolyPeptide
- Why Legend Biotech stock fell 10% despite record Carvykti sales
- Virtual Therapy Sessions Improve Lives Of Kids With Lupus
- More Evidence Links Sleep Apnea To Dementia And Memory Loss
- Study Links GLP-1 Medications To Rare Vision Issue
- Gut Bacteria May Hold Key To Preventing Severe Peanut Allergies
- Tempus buys out cancer genomics partner Personalis in $1.5 billion deal
- Trump's CDC Nominee Praises Vaccines, Without Vowing Independence From RFK Jr.
- Doctors ‘Cringe’ at Possibility of Documenting Which Medicaid Enrollees Too Sick To Work
- Pregnant Woman’s Roadside Death Triggers Push To Reopen Mississippi Delta Hospital
- Violence Repeatedly Erupts at Dementia Care Facilities Despite Warnings, Inspections Show
- Journalists Dig Into HHS’ Covid Injury List, ACA Sign-Ups, and Telehealth
- CDC Warns Of Parasite Outbreak Tied To Taco Bell Lettuce In 5 States
- The Best Vegetables For Your Heart May Depend On Your Sex
- One Type Of ADHD Med May Affect Kids' Weight
- Poll: Many Older Americans Unaware Of 988 Suicide Help Line
- Black Americans Born Abroad Have Lower Odds For Stroke, Study Finds
- A Hidden Influence On Teen Girls' Emotions: Testosterone
- A Sales Tax On Doctor Visits And Medicine? In Missouri, Some Worry
- Watch: ‘Robust’ Primary Care, Transparency Top Employers’ Reform Wish List
- Big Pharma’s Big Brand: Novartis reconnects to its past as it moves forward
- Why Commercial Evidence Is the Next Breakthrough in Pharma Intelligence
- FDA Clears First Cholesterol Pill, Lipfendra, To Rival Costly Injections
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- One Of The Largest Epidural Studies Ever Delivers Reassuring News For Parents
- Could A Vaccine Prevent Pancreatic Cancer In Those At High Risk?
- Heatwaves During Pregnancy Could Affect Baby's Brain Development, Study Suggests
- Brain 'Microstimulation' Works Long-Term To Restore Sense Of Touch After Spinal Cord Injury
- 'Night Owls' At Risk Of Wider Waistlines, Unhealthy Hearts
- Facing Funding Losses, States Call Out Big Businesses With Employees On Medicaid
- Wildfire Smoke Puts Millions At Risk Across Midwest, Northeast
- Are Microplastics Linked To Higher Heart Attack Risk?
- Impulsivity In Third Grade Could Point To Future Struggles
- AI Can Create 'Ghosts' Of Lost Loved Ones, But Would You Want To Meet Them?
- Access: A key driver of non-opioid pain management adoption
- Remarks before the American-Hellenic Chamber of Commerce
- CDMO trends reshaping biopharma manufacturing
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
Michigan healthcare freedom community forum
Chris Pope of The Manhattan Institute believes that preventing states from creating new, extraneous programs and funding them with Medicaid dollars is the best way to cut Medicaid spending. A good idea, but unlikely to actually cut Medicaid spending. More likely to reduce the explosive growth of Medicaid spending which has occurred in this century. Federal Medicaid expenditures have increased from $ 118 billion in FY2000 to $ 557 billion in FY2024, a 472% increase:
https://www.city-journal.org/article/house-republicans-medicaid-spending-proposals
A Better Way to Cut Medicaid Spending
The House GOP’s current plans won’t significantly reduce the program. Republicans should instead seek to slow states’ expansions of it.
By Chris Pope - May 20, 2025Last week, House Republicans unveiled proposals to reform Medicaid, the fast-growing system of federal funding for states to deliver health care to low-income Americans. Their proposal creates the appearance of generating substantial savings by nudging states to restrict enrollment. But the approach is unlikely to slow the overall growth of Medicaid spending, because it does little to reduce states’ ability and incentive to claim ever more federal funding.
In reality, Republicans, who promised not to threaten care for those enrolled, have been unable to identify substantial savings by cutting funds that states rely on to deliver health care to Medicaid enrollees. They would do better to focus on the politically easier and fiscally more significant task of preventing states from further expanding the program’s commitments.
Liberals responded to the House’s modest proposals with predictable outrage. Matthew Yglesias has called it a “War on the poor,” arguing that “Medicaid cuts contained in the bill will cause 8.6 million people to lose their health insurance.” Massachusetts representative Lori Trahan has deemed it “federal overreach, plain and simple, with devastating consequences for the people we represent.”
Critics’ outrage is surely overdone. From 2003 to 2023, Medicaid’s annual cost to federal taxpayers surged from $161 billion to $616 billion. House Republicans’ proposals would merely slow the program’s further spending growth over the coming decade from 4.6 percent per year to 3.7 percent. Even that reduction in growth is likely to overestimate the savings that would occur.
To offset the cost of extending the 2017 tax cuts, the House GOP has attempted to maximize the Congressional Budget Office’s estimate of savings resulting from its proposed reforms to Medicaid. But CBO estimates don’t account for likely hurdles to implementation, such as states finding ways to evade intended cost controls.
When such hurdles are considered, the savings and coverage loss are both much less than they’re cracked up to be. This is by design—and it reflects the GOP’s tiny majorities in both houses of Congress, combined with political pressure from governors and health-care providers who stand to lose revenues.
Opponents of the bill point to major cuts in coverage, which the CBO suggests would generate reductions in spending. Loren Adler and Matthew Fiedler of the Brookings Institution, for example, argue that “House Republicans are cutting health coverage programs in two basic ways: (1) narrowing eligibility and making it harder to enroll and stay enrolled; and (2) shifting Medicaid costs from the federal government to the states.” But neither of these effects are likely to be that large.
Take the bill’s work requirements. Adler and Fielder concede that work requirements would not greatly narrow eligibility because the “overwhelming majority of affected enrollees are already working or otherwise complying.” But they suggest that the administrative burden of demonstrating compliance may lead many who are eligible to lose benefits.
That seems unlikely. The bill allows part-time “community engagement” activities to satisfy work requirements, and states have proven adept at using token employment arrangements to nullify similar mandates in the past. The bill would not even allow states to implement work requirements for several years.
States currently receive up to $9 in federal funds for every $1 they spend on Medicaid benefits for able-bodied adults—a return on investment that even most conservative states have found hard to resist. An important objective of work requirements appears to be giving the remaining holdouts political cover to claim their own portion of the federal bounty by expanding Medicaid. This would greatly increase, rather than reduce, federal spending and Medicaid enrollment—even if CBO does not account for such considerations.
Republicans argue that it’s absurd for the federal government to provide $9 in funding for every $1 states spend on Medicaid benefits for able-bodied adults, while only providing an average of $1.30 for every $1 spent on benefits for children, the disabled, and pregnant women. President Obama proposed replacing this arrangement with an intermediary rate for all beneficiaries, but Republicans plan simply to reduce the higher rate.
Democrats argue that the proposed reduction of funding for states would lead to major cuts in coverage. But the GOP bill would only trim the $9-to-$1 match to $8-to-$1 for blue states whose Medicaid providers also deliver care to illegal immigrants—leaving an enormously lucrative arrangement largely in place. The reduction is more an attempt to influence states’ policies on immigration than an effort to lessen substantially the burden on federal taxpayers.
The House GOP bill may nonetheless generate some modest genuine savings. It tightens enforcement of means tests and attempts to restrict states’ ability to inflate federal matching funds artificially by imposing state taxes on insurers, hospitals, and other medical providers. But similar restrictions on “provider taxes” have been enacted in the past and tend to proceed like a game of Whac-a-Mole: whenever Congress restricts one scheme to inflate Medicaid costs artificially, states construct another.
The only real way to stop states from driving up Medicaid costs is to limit the total amount of federal Medicaid funding each state may claim. This year’s House GOP proposal, unlike the 2017 version, doesn’t even try to do so. The GOP has previously stumbled in attempting to set precise dollar limits on Medicaid funding for states. (Set them too high, and they will do little to constrain the growth of expenditures; too low, and they will unduly disrupt existing care.)
A better approach would be to prohibit high-spending states from unilaterally expanding their Medicaid programs. States that claim more than $20,000 in federal Medicaid funds per poor resident should no longer be permitted to claim additional matching funds for further expansions of benefit packages or eligibility, or extraordinary increases in payments for services undertaken without express authorization by Congress.
The House GOP’s Medicaid reform proposals have failed to generate substantial genuine savings or improvements to the program. Their Republican Senate counterparts have an opportunity to do better.
Christopher Pope is a senior fellow at the Manhattan Institute. Previously, he was director of policy research at West Health, a nonprofit medical research organization; health-policy fellow at the U.S. House Committee on Energy and Commerce; and research manager at the American Enterprise Institute. Pope’s research focuses on healthcare payment policy, and he has recently published reports on hospital-market regulation, entitlement design, and insurance-market reform. His work has appeared in, among others, the Wall Street Journal, Health Affairs, US News and World Report, and Politico.
Pope holds a B.Sc. in government and economics from the London School of Economics and an M.A. and Ph.D. in political science from Washington University in St. Louis.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















